Analyzing Cell-Free DNA from Cancer Patients to Identify Actionable Variants

Analyzing Cell-Free DNA from Cancer Patients to Identify Actionable Variants

In this webinar, whole exome sequencing data of tumor tissue and cell-free DNA derived from two cancer patients will be used to demonstrate how non-invasive liquid biopsies from the blood have the potential to aid in precision medicine. Using Partek Flow software, a powerful and easy-to-use bioinformatics tool, we will analyze raw sequence data from individuals with metastatic sarcoma and metastatic breast cancer to identify clinically actionable variants.

Agenda:

• Align and filter whole exome sequencing data
• Detect variants from tumor and cell-free DNA
• Perform annotation and filtering to prioritize variants